Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy — Stella

Home/Advanced Gynecological Malignancy/A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy

View on ClinicalTrials.gov

Recruiting

Back to Advanced Gynecological Malignancy trials

A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong

Key details

Phase

Safety & dosing

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.

Enrollment target

~100 participants

Started

November 2024

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Sex

Female only

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.